Division of Becton Dickinson & Co.
Latest From Medafor Inc.
Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.
Medtronic sold its Pioneer Plus diagnostic ultrasound transducer and percutaneous catheter to Volcano for $15 million; boosting its position in generic ophthalmics, Akorn acquired Hi-Tech Pharmacal for $591 million. Biopharma and device financing each decreased in August compared with the previous month, with both segments at six-month lows.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-September 2013.
Rochester’s main products are silicone male external catheters for male urinary incontinence and silicone intermittent catheters for urinary retention, constituting a global home care urology market worth $930 million.
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- North America
- Parent & Subsidiaries
- Becton Dickinson & Co.
- Senior Management
Gary Shope, CEO
Gerald Doran, VP, CFO
Robert Cerza, EVP, Bus. Dev.
- Contact Info
Phone: (877) 633-2367
2700 Freeway Blvd.
Minneapolis, MN 55430
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.